SCHEMBL23263221

SCHEMBL23263221

O=c1ccccc(Oc2ccc(F)cc2)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ HSP90AB1 P08238 1/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAP2K1 Q02750 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.44
▸ CES2 O00748 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ DBH P09172 1/20 0.42
▸ SCN8A Q9UQD0 2/20 0.42
▸ SCN10A Q9Y5Y9 2/20 0.42
▸ PNLIP P16233 1/20 0.42
▸ HDAC4 P56524 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11449754 0.86 CTNNB1 (0.48) ALDH1A1LMNAHPGDMAPTDBH
SCHEMBL27019059 0.78 HSP90AA1 (0.41) ALDH1A1L3MBTL1LMNAKDM4EHPGD
SCHEMBL23249850 0.77 HSPB1 (0.44) ALDH1A1PNLIPHTT
SCHEMBL6290676 0.77 ALDH1A1 (0.61) ALDH1A1L3MBTL1LMNAMAPK1MAPT
SCHEMBL9837352 0.76 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNAHSP90AA1HSP90AB1
SCHEMBL6289924 0.75 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNAMAPK1MAPT
SCHEMBL6293775 0.75 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNAMAPK1MAPT
SCHEMBL6290609 0.75 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNAMAPK1MAPT
SCHEMBL6293841 0.75 L3MBTL1 (0.58) ALDH1A1L3MBTL1LMNAMAPK1MAPT
SCHEMBL27018675 0.75 PIK3CD (0.42) SCN8ASCN10AHDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073131-A2 METHOD OF TREATING NEURODEGENERATIVE DISEASES THE BOARD OF TRUSTEES OF THE UNIVESITY OF ILLINOIS (US) 2024-04-04 — — WO disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
EP-4045025-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2022-08-24 — — EP disclosed
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TXNRD1, SDHB ALDH1A1 848/4885L3MBTL1 2606/4885LMNA 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback